Multivariate analysis of prognostic factors for OS in AML
| Variable . | Total population . | Censored for allograft . | ||||
|---|---|---|---|---|---|---|
| HR . | 95% CI . | P . | HR . | 95% CI . | P . | |
| High INPP4B | 2.2 | 1.27-3.67 | <.01 | 2.0 | 1.1-3.66 | .02 |
| Adverse karyotype | 1.74 | 1.07-2.81 | .03 | 1.55 | 0.87-2.74 | .14 |
| Age >55 y | 2.13 | 1.43-3.18 | <.01 | 6.3 | 3.48-11.57 | <.01 |
| WBC >100 × 109/L | 1.7 | 0.92-3.19 | .09 | 1.62 | 0.73-3.6 | .24 |
| Secondary AML | 1.65 | 0.89-3.06 | .11 | 1.91 | 0.85-4.26 | .12 |
| Variable . | Total population . | Censored for allograft . | ||||
|---|---|---|---|---|---|---|
| HR . | 95% CI . | P . | HR . | 95% CI . | P . | |
| High INPP4B | 2.2 | 1.27-3.67 | <.01 | 2.0 | 1.1-3.66 | .02 |
| Adverse karyotype | 1.74 | 1.07-2.81 | .03 | 1.55 | 0.87-2.74 | .14 |
| Age >55 y | 2.13 | 1.43-3.18 | <.01 | 6.3 | 3.48-11.57 | <.01 |
| WBC >100 × 109/L | 1.7 | 0.92-3.19 | .09 | 1.62 | 0.73-3.6 | .24 |
| Secondary AML | 1.65 | 0.89-3.06 | .11 | 1.91 | 0.85-4.26 | .12 |
CI, confidence interval.